1. Reducing lipids for CV protection in CKD patients—current evidence
Christoph Wanner, Eberhard Ritz 
Kidney International 
Volume 74, Pages S24-S28 (December 2008)
DOI: /ki
Copyright © 2008 International Society of Nephrology Terms and Conditions

2. Figure 1
Triglyceride-enriched very low-density lipoprotein (VLDL) activates nuclear factor-kappa B (NF-κB), which plays a key role in activating a spectrum of pro-inflammatory genes, leading to endothelial dysfunction and oxidative stress. NFκB, nuclear factor κB; IL-6, interleukin 6; COX-2, cyclooxygenase-2; TNF-α, tumor necrosis factor-α; ICAM, intracellular adhesion molecule; VCAM, vascular cell adhesion molecule; ApoCIII, apolipoprotein CIII.
Kidney International  , S24-S28DOI: ( /ki )
Copyright © 2008 International Society of Nephrology Terms and Conditions